カテゴリ： GlobalData, 企業調査, 日本

Terumo Corp (4543)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Terumo Corp (4543) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C11431
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：83
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

Terumo Corp (4543) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Terumo Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Terumo Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Terumo Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Terumo Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Terumo Corp, Medical Equipment, Deal Details 14
Asset Purchase 14
Terumo to Acquire Large Bore Vascular Closure System from Medeon Biodesign 14
Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 15
Terumo Acquires Orpheus Simulator Technology From Ulco Technologies 17
Venture Financing 18
Sequent Medical Raises US$20 Million In Venture Financing 18
Sequent Medical Raises US$26 Million In Series C Financing 19
Partnerships 20
Terumo Enters into Licensing Agreement with ivWatch 20
Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 21
Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology 22
Terumo Enters into Distribution Agreement with DexCom 23
Cohera Medical Enters into Distribution Agreement with Terumo 24
Terumo Enters into Distribution Agreement with Xenex Disinfection Services 25
Terumo BCT Partners with Biomedical Advanced Research and Development Authority 26
Terumo Enters into Distribution Agreement with Quirem Medical 27
Angiocrine Bioscience Enters into Agreement with Terumo BCT 28
Terumo Enters into Distribution Agreement with Olympus Medical Systems 29
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 30
Terumo Expands Distribution Agreement with Olympus 31
Terumo Cardiovascular Systems Expands Distribution Agreement with Nonin Medical for SenSmart Model X-100 Universal Oximetry System 32
Arterial Remodeling Technologies Enters Into Co-Development Agreement With Terumo For Bioresorbable Scaffold 33
Terumo BCT Extends Distribution Agreement With Therakos 34
Terumo Enters Into Distribution Agreement With CareFusion For SurFlash Catheters In US 35
Nonin Medical Enters Into Distribution Agreement With Terumo Europe For SenSmart Universal Oximetry System 36
Terumo BCT Expands Agreement with Mallinckrodt 37
BSD Medical Enters Into Distribution Agreement With Terumo Europe 38
Terumo Cardiovascular Systems Enters Into Distribution Agreement With Nonin Medical 39
Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 40
RS Medical Enters Into Distribution Agreement With Harvest Technologies 41
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 42
Terumo Cardiovascular Enters Into Distribution Agreement With LAAx 43
Merger 44
Vascutek Merges with Bolton Medical 44
Equity Offering 45
Quirem Medical Raises Funds through Private Placement of Shares 45
Debt Offering 46
Terumo Completes Public Offering Of Series 3 Unsecured Straight Bonds Due 2015 For US$500 Million 46
Terumo Completes Public Offering Of Series 4 Unsecured Straight Bonds Due 2017 For US$500 Million 47
Asset Transactions 48
MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems 48
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 49
Acquisition 51
Terumo Aortic Acquires Serom Medical Technology 51
Terumo to Acquire Essen Technology for USD130 Million 52
Terumo Acquires Bolton Medical from Werfen Life for USD174 Million 53
Terumo Acquires Sequent Medical 54
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 55
Terumo Acquires An Innovative Sheath Technology Company, Onset Medical 56
Terumo Corp – Key Competitors 57
Terumo Corp – Key Employees 58
Terumo Corp – Locations And Subsidiaries 61
Head Office 61
Other Locations & Subsidiaries 61
Joint Venture 64
Recent Developments 65
Strategy And Business Planning 65
Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 65
Sep 28, 2017: Terumo Opens a New Innovation Center in Southern California 66
Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 67
Jan 31, 2017: Terumo Opens a Branch in Yangon 68
Financial Announcements 69
Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 69
Corporate Communications 70
Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor 70
Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor 71
May 11, 2018: Terumo Appoints its U.S. based Subsidiary’s Associate as the Fifth Terumo Fellow 72
Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 73
Feb 09, 2017: Terumo Announces Change of Executive Officers 75
Legal and Regulatory 76
Apr 23, 2018: Vascutek and Bolton Medical Merge as ‘Terumo Aortic’ 76
Government and Public Interest 77
Jul 04, 2018: Terumo Announces Shipping Delays for Products from Ashitaka Factory 77
Product News 78
Jan 30, 2017: Terumo launches user friendly PLAJEX Luer Lock with Threaded Closure (TC) 78
Jan 26, 2017: Terumo and Nemera announce compatibility between PLAJEX polymer prefillable syringes and Safe’n'Sound 79
Other Significant Developments 80
Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 80
Feb 13, 2018: Terumo Announces £33m Investment in Scottish Medical Device Factory 81
Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 82
Appendix 83
Methodology 83
About GlobalData 83
Contact Us 83
Disclaimer 83

List of Tables
Terumo Corp, Medical Equipment, Key Facts, 2018 2
Terumo Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Terumo Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Terumo Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Terumo Corp, Deals By Market, 2012 to YTD 2018 10
Terumo Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Terumo to Acquire Large Bore Vascular Closure System from Medeon Biodesign 14
Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 15
Terumo Acquires Orpheus Simulator Technology From Ulco Technologies 17
Sequent Medical Raises US$20 Million In Venture Financing 18
Sequent Medical Raises US$26 Million In Series C Financing 19
Terumo Enters into Licensing Agreement with ivWatch 20
Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 21
Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology 22
Terumo Enters into Distribution Agreement with DexCom 23
Cohera Medical Enters into Distribution Agreement with Terumo 24
Terumo Enters into Distribution Agreement with Xenex Disinfection Services 25
Terumo BCT Partners with Biomedical Advanced Research and Development Authority 26
Terumo Enters into Distribution Agreement with Quirem Medical 27
Angiocrine Bioscience Enters into Agreement with Terumo BCT 28
Terumo Enters into Distribution Agreement with Olympus Medical Systems 29
Olympus Medical Enters into Distribution Agreement with Terumo Corporation 30
Terumo Expands Distribution Agreement with Olympus 31
Terumo Cardiovascular Systems Expands Distribution Agreement with Nonin Medical for SenSmart Model X-100 Universal Oximetry System 32
Arterial Remodeling Technologies Enters Into Co-Development Agreement With Terumo For Bioresorbable Scaffold 33
Terumo BCT Extends Distribution Agreement With Therakos 34
Terumo Enters Into Distribution Agreement With CareFusion For SurFlash Catheters In US 35
Nonin Medical Enters Into Distribution Agreement With Terumo Europe For SenSmart Universal Oximetry System 36
Terumo BCT Expands Agreement with Mallinckrodt 37
BSD Medical Enters Into Distribution Agreement With Terumo Europe 38
Terumo Cardiovascular Systems Enters Into Distribution Agreement With Nonin Medical 39
Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 40
RS Medical Enters Into Distribution Agreement With Harvest Technologies 41
Daiichi Sankyo Enters Into Co-Development Agreement With Terumo For Intradermal Vaccine 42
Terumo Cardiovascular Enters Into Distribution Agreement With LAAx 43
Vascutek Merges with Bolton Medical 44
Quirem Medical Raises Funds through Private Placement of Shares 45
Terumo Completes Public Offering Of Series 3 Unsecured Straight Bonds Due 2015 For US$500 Million 46
Terumo Completes Public Offering Of Series 4 Unsecured Straight Bonds Due 2017 For US$500 Million 47
MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems 48
Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US$56.5 Million 49
Terumo Aortic Acquires Serom Medical Technology 51
Terumo to Acquire Essen Technology for USD130 Million 52
Terumo Acquires Bolton Medical from Werfen Life for USD174 Million 53
Terumo Acquires Sequent Medical 54
Terumo BCT To Acquire Gada Turkey, Medical Device Distributor 55
Terumo Acquires An Innovative Sheath Technology Company, Onset Medical 56
Terumo Corp, Key Competitors 57
Terumo Corp, Key Employees 58
Terumo Corp, Other Locations 61
Terumo Corp, Subsidiaries 62
Terumo Corp, Joint Venture 64

List of Figures
Terumo Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Terumo Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Terumo Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Terumo Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Terumo Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Terumo Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Terumo Corp (4543)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CareGroup Inc：企業の戦略的SWOT分析
    CareGroup Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Olon SpA：製薬・医療：M&Aディール及び事業提携情報
    Summary Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, aba …
  • Lectra S.A. (LSS)：企業の財務・戦略的SWOT分析
    Lectra S.A. (LSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chesapeake Energy Corp (CHK)：企業の財務・戦略的SWOT分析
    Chesapeake Energy Corp (CHK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PPL Corporation (PPL)：石油・ガス：M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Miromatrix Medical Inc：製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • ProAxsis Ltd-医療機器分野：企業M&A・提携分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Inframark LLC：企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • AeroParts Manufacturing & Repair, Inc：企業の戦略・SWOT・財務情報
    AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report Summary AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Samba Private Banking：企業の戦略・SWOT・財務分析
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Icagen Inc：企業のM&A・事業提携・投資動向
    Icagen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icagen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • National Bank Of Bahrain Bsc：企業の戦略・SWOT・財務分析
    National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Vista Gold Corp.：企業の戦略・SWOT・財務情報
    Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report Summary Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HeidelbergCement AG：企業のM&A・事業提携・投資動向
    HeidelbergCement AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HeidelbergCement AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Metalico Inc：企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Guided Therapeutics Inc (GTHP)：企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Siemens AG (SIE)：企業の財務・戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Koki Holdings Co Ltd：企業の戦略的SWOT分析
    Koki Holdings Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BioLamina AB-製薬・医療分野：企業M&A・提携分析
    Summary BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio inc …
  • In-N-Out Burgers：企業の戦略・SWOT・財務情報
    In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report Summary In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆